Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ Pan Ankyrin Monoclonal Antibody (S388A-60)
Mouse Monoclonal Antibody
Supplier: Invitrogen™ MA527722
Description
Pan Ankyrin Monoclonal Antibody for Western Blot, ICC/IF, IHC (PFA)
Ankyrins are a family of adaptor proteins that mediate the attachment of integral membrane proteins to the spectrin-actin based membrane skeleton. Ankyrins have binding sites for the beta subunit of spectrin and at least 12 families of integral membrane proteins. This linkage is required to maintain the integrity of the plasma membranes and to anchor specific ion channels, ion exchangers and ion transporters in the plasma membrane.
Specifications
Pan Ankyrin | |
Monoclonal | |
1 mg/mL | |
PBS with 50% glycerol and 0.1% sodium azide; pH 7.4 | |
G5E8K5, O70511, P16157, Q01484, Q02357, Q12955, Q8C8R3 | |
Ank1, Ank2, Ank3 | |
Fusion protein amino acids 1-1881 (full-length) of human Ankyrin-R. | |
100 μg | |
Primary | |
Human, Mouse, Rat | |
Antibody | |
IgG1 |
Immunohistochemistry (PFA fixed), Western Blot, Immunocytochemistry | |
S388A-60 | |
Unconjugated | |
Ank1 | |
2900054D09Rik; AI314020; AI835472; ANK; ANK1; Ank-1; ANK2; Ank-2; Ank3; ANK-3; AnkB; AnkG; ankyrin 1; ankyrin 1, erythrocytic; ankyrin 1, erythroid; ankyrin 2, brain; ankyrin 2, neuronal; ankyrin 3 (G); ankyrin 3, epithelial; ankyrin 3, node of Ranvier (ankyrin G); ankyrin B; ankyrin, brain; ankyrin-1; Ankyrin-2; ankyrin-2, nonerythrocytic; ankyrin-3; Ankyrin-B; ankyrin-G; Ankyrin-R; AW491075; Brain ankyrin; brain-specific ankyrin-G; brank-2; Erythrocyte ankyrin; LQT4; MRT37; nb; non-erythroid ankyrin; normoblastic anemia; pale; rCG_43073; SPH1; SPH2 | |
Mouse | |
Protein G | |
RUO | |
109676, 11733, 11735, 286, 287, 288, 306570, 361833, 362036 | |
-20°C | |
Liquid |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction